<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang</h2>
    <div class="badge">2025-09-08T20:05:00+00:00</div>
    <ul>
      <li>08, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc.</li>
<li>NEXICART-2 primary endpoint was met at interim results presented at ASCO 2025.</li>
<li>NXC-201 is being evaluated in the U.S.</li>
<li>Phase 1/2 clinical trial; (iii) the risk that the Company may not be able to advance to registration-enabling studies for CAR-T NXC-201 or other product candidates, (iv) that success in early phases of pre-clinical and c</li>
<li>multi-center study for relapsed/refractory AL Amyloidosis NEXICART-2 (NCT06097832), with a registrational design.</li>
<li>Dr.</li>
<li>CEO Dr.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang\n• 08, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc.\n• NEXICART-2 primary endpoint was met at interim results presented at ASCO 2025.\n• NXC-201 is being evaluated in the U.S.\n• Phase 1/2 clinical trial; (iii) the risk that the Company may not be able to advance to registration-enabling studies for CAR-T NXC-201 or other product candidates, (iv) that success in early phases of pre-clinical and c\n• multi-center study for relapsed/refractory AL Amyloidosis NEXICART-2 (NCT06097832), with a registrational design.\n• Dr.\n• CEO Dr." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/immix-biopharma-announces-strategic-investment-200500034.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>